LAUREN P SILVERNAIL Insider Trading $EOLS Evolus, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LAUREN P SILVERNAIL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LAUREN P SILVERNAIL. LAUREN P SILVERNAIL is CFO in ISTA PHARMACEUTICALS INC ($ISTA) and Chief Financial Officer in ISTA PHARMACEUTICALS INC ($ISTA) and CFO & CBO in Revance Therapeutics, Inc. ($RVNC) and CFO, CBO & Secretary in Revance Therapeutics, Inc. ($RVNC) and CFO, Secretary & EVP Corp Dev. in Revance Therapeutics, Inc. ($RVNC) and See Remarks in Evolus, Inc. ($EOLS).
LAUREN P SILVERNAIL in Evolus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAUREN P SILVERNAIL: See Remarks
Holdings: 180,689 shares
Latest Transaction: Feb 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LAUREN P SILVERNAIL in Evolus, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EOLS, ISTA, RVNC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 90,000 | 0 | 180,689 | 90.7 K to 180.7 K (+99.24 %) |
| Jan 26 2021 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 7.46 | 2,699 | 20,135 | 90,689 | 93.4 K to 90.7 K (-2.89 %) |
| May 15 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 40,000 | 0 | 93,388 | 53.4 K to 93.4 K (+74.92 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Option Exercise | A | 10.19 | 45,000 | 458,550 | 45,000 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 26,000 | 0 | 53,388 | 27.4 K to 53.4 K (+94.93 %) |
| May 31 2019 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 13.53 | 2,612 | 35,352 | 27,388 | 30 K to 27.4 K (-8.71 %) |
| May 31 2019 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 13.53 | 2,612 | 35,352 | 27,388 | 30 K to 27.4 K (-8.71 %) |
| Jan 25 2019 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Option Exercise | A | 16.19 | 45,000 | 728,550 | 45,000 | |
| May 31 2018 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Option Exercise | A | 22.44 | 200,000 | 4,488,000 | 200,000 | |
| May 31 2018 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Page: 1